Kadant Inc. — Form 10-Q Summary
Period: Fiscal third quarter ended October 1, 2022, and first nine months of 2022, compared with the corresponding 2021 periods. The request metadata says “2021 Q3,” but the filing is for 2022 Q3.
Business context and results
Kadant supplies engineered technologies for sustainable industrial processing through Flow Control, Industrial Processing, and Material Handling. Its markets include paper and packaging, wood processing, aggregates, mining, food, and waste management.
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Revenue | $224.5 million | $199.8 million | $672.6 million | $568.1 million |
| Gross margin | 42.5% | 41.9% | 43.1% | 43.1% |
| Operating income | $38.9 million | $28.7 million | $132.3 million | $85.2 million |
| Net income attributable to Kadant | $27.5 million | $20.5 million | $94.8 million | $59.9 million |
| Diluted EPS | $2.35 | $1.75 | $8.12 | $5.14 |
| Operating cash flow | Not separately presented | Not separately presented | $67.5 million | $101.4 million |
| Free cash flow (non-GAAP) | $18.5 million | $34.6 million | $51.3 million | $93.7 million |
Q3 revenue increased 12%; organic revenue, excluding acquisitions and currency effects, increased 19%. Nine-month revenue rose 18%, including a 7% acquisition contribution and a 5% unfavorable currency impact; organic revenue increased 16%. Q3 revenue growth occurred in all segments. For the first nine months, revenue increased in all three segments, while consolidated gross margin was unchanged year over year.
Cash, debt, and liquidity
- Cash and cash equivalents were $72.9 million at October 1, 2022, down from $91.2 million at January 1, 2022. Working capital was $188.0 million, versus $162.4 million.
- Nine-month operating cash flow fell to $67.5 million, primarily because of working-capital investment: inventory and accounts receivable used $54.5 million. Inventory rose to $156.6 million from $134.4 million.
- Total short- and long-term obligations were $209.7 million, including $195.0 million outstanding under the revolving facility. Kadant had $206.3 million of facility borrowing capacity available, plus a $150 million uncommitted incremental facility. The reported leverage ratio was 0.94; the company said it was covenant-compliant.
- Financing activities used $62.1 million during the nine months, including $69.5 million of debt repayments. Investing activities used $13.9 million, including $16.2 million of capital expenditures.
Material changes and unusual items
- Reported nine-month operating income included a $20.2 million pretax gain on the sale of a Chinese manufacturing facility and land-use rights. The sale proceeds were approximately $25.2 million; $14.6 million remained receivable at quarter-end. Kadant plans to relocate the operation and build a replacement facility.
- The company reported $182,000 of impairment costs and $72,000 of Q3 restructuring costs. The restructuring relates to eliminating a redundant ceramic blade operation following the Clouth acquisition.
- The stronger U.S. dollar reduced nine-month revenue by $27.0 million, and currency translation reduced cash by $10.5 million. Accumulated other comprehensive items also declined, primarily due to foreign currency translation.
- Debt declined from $269.5 million at January 1, 2022. Interest expense increased, reflecting higher average borrowing rates, partly offset by lower average debt.
Outlook, management commentary, and risks
- Bookings were $210.9 million in Q3, below Q1 and Q2 2022 levels and Q3 2021. Capital-equipment demand fell 39% sequentially, chiefly in Industrial Processing. Backlog was $350.3 million at quarter-end.
- Management expected Q4 bookings to be lower than prior quarters as demand moderates amid inflation-control measures by central banks. It anticipated moderation across segments, while expecting sequentially higher Industrial Processing capital bookings than in Q3, but below Q1 and Q2 levels.
- Labor availability and supply-chain constraints continued to cause longer lead times and higher material and freight costs. The company cited pricing actions and advance raw-material purchases as mitigation measures. It nevertheless described business fundamentals as positive, supported by backlog and market demand.
- Key exposures include macroeconomic demand slowdown, inflation, supply-chain disruption, foreign exchange, tariffs and trade restrictions, geopolitical developments, and COVID-19-related disruption, particularly China’s zero-COVID policy. Management said existing cash, operating cash flow, and borrowing capacity should meet requirements for the next 12 months and foreseeable future.
- The board authorized up to $50 million of share repurchases through May 19, 2023; no shares had been repurchased under that authorization as of the filing. Management expected to renew the revolving credit facility before its December 2023 maturity.
Important facts for investors to verify
- Confirm the distinction between reported earnings and adjusted results, especially the $20.2 million facility-sale gain in nine-month operating income.
- Monitor bookings, backlog conversion, and capital-equipment demand as management anticipated softer bookings in Q4.
- Track working-capital consumption, inventory, and operating cash flow; free cash flow was substantially below the prior-year period.
- Assess currency, supply-chain, China-related, and geopolitical risks and their effects on margins and customer deliveries.
- Review progress on the China replacement facility, collection of the remaining sale receivable, and renewal of the credit facility before maturity.